巨噬细胞移动抑制因子在肉芽肿性多血管炎中的作用
研究探讨巨噬细胞移动抑制因子(MIF)启动子多态性与肉芽肿性多血管炎(GPA)的关联,并在小鼠肉芽肿性血管炎模型中评估MIF的作用。人研究纳入1077例GPA患者和健康对照,检测MIF -794 CATT5-8启动子微卫星(rs5844572);小鼠实验用白色念珠菌β-葡聚糖诱导肉芽肿病,比较野生型、Mif敲除及肺上皮过表达Mif转基因小鼠,并予抗MIF中和抗体治疗。结果显示GPA患者高表达CATT等位基因频率高于对照(60.2% vs 53.9%,校正P=0.049),Mif肺转基因小鼠肺肉芽肿更多、死亡率更高,抗MIF单抗可保护其免于死亡。
要点
- GPA患者携带>5个CATT重复的高基因型MIF表达者比例为60.2%,健康对照为53.9%(校正P=0.049)。
- 人MIF基因表达随CATT长度增加而成比例升高。
- Mif肺转基因小鼠肺肉芽肿数量多于野生型,野生型多于Mif敲除小鼠;抗MIF单抗可保护转基因小鼠免于致死结局。
核心结论
- GPA患者高MIF表达CATT等位基因频率增加;Mif高表达增加Mif肺转基因小鼠死亡率和肺肉芽肿发生率,抗MIF治疗可保护这些小鼠免于死亡;作者认为在高基因型MIF表达者中阻断MIF可能为GPA提供选择性药物治疗。
研究设计与样本
- 人研究纳入1077例GPA患者和健康对照,用毛细管电泳对MIF -794 CATT5-8启动子微卫星(rs5844572)进行基因分型,并用基因报告试验评估β-葡聚糖刺激下CATT长度依赖的MIF启动子基因表达。
- 小鼠研究将白色念珠菌β-葡聚糖注射入野生型(WT)、Mif敲除(Mif-KO)C57BL/6小鼠及肺上皮过表达Mif的C57BL/6转基因小鼠(Mif lung-Tg2.1)诱导肉芽肿病,并用抗MIF中和抗体治疗,分析肺肉芽肿密度、炎症趋化因子表达和死亡率。
主要发现
- 每个MIF等位基因携带>5个CATT重复(高基因型MIF表达者)的比例在GPA患者为60.2%,健康对照为53.9%(校正P=0.049)。
- 人MIF基因表达在肉芽肿刺激下随CATT长度成比例增加。
- Mif lung-Tg2.1小鼠肺肉芽肿多于WT小鼠,WT小鼠多于Mif-KO小鼠。
- 注射白色念珠菌β-葡聚糖后,Mif lung-Tg2.1小鼠死亡百分比显著高于Mif-KO或WT小鼠,抗MIF单克隆抗体治疗可保护这些小鼠免于致死结局。
- Mif lung-Tg2.1小鼠支气管肺泡灌洗液或血浆中MIF依赖性中性粒细胞/巨噬细胞趋化因子水平升高。
关键数值与推荐
- 高基因型MIF表达者定义为每个MIF等位基因携带>5个CATT重复,GPA患者中占60.2%,健康对照中占53.9%(校正P=0.049)。
临床怎么用
- 作者认为在高基因型MIF表达者中阻断MIF可能为GPA提供选择性药物治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between macrophage migration inhibitory factor (MIF) promoter polymorphisms and granulomatosis with polyangiitis (GPA) in human subjects, and to assess the role of MIF in a murine model of granulomatous vasculitis. METHODS: The human study involved 1,077 patients with GPA and healthy controls whose serum was genotyped by capillary electrophoresis for the MIF -794 CATT5-8 promoter microsatellite (rs5844572). MIF promoter, CATT-length-dependent gene expression in response to β-glucan was assessed by gene reporter assays. In mouse studies, granulomatous disease was induced by injection of Candida albicans β-glucan into wild-type (WT) or Mif-knockout (Mif-KO) C57BL/6 mice and C57BL/6 mice transgenically overexpressing Mif in lung epithelium (Mif lung-Tg2.1). Mice were treated with a neutralizing anti-MIF antibody and analyzed for the density of pulmonary granulomas, expression of inflammatory chemokines, and frequency of mortality. RESULTS: The percentage of human subjects carrying >5 CATT repeats in each MIF allele (high genotypic MIF expressers) was 60.2% among patients with GPA and 53.9% among healthy controls (adjusted P = 0.049). In response to granulomatous stimulation, human MIF gene expression increased proportionally with CATT length. Mif lung-Tg2.1 mice exhibited more pulmonary granulomas than WT mice, which in turn showed more granulomas than Mif-KO mice. A significantly higher percentage of Mif lung-Tg2.1 mice, compared to Mif-KO or WT mice, died when injected with Candida albicans β-glucan, and treatment of these mice with an anti-MIF monoclonal antibody protected against a lethal outcome. Levels of MIF-dependent neutrophil/macrophage chemokines were elevated in the bronchoalveolar lavage fluid or plasma of Mif lung-Tg2.1 mice. CONCLUSION: Patients with GPA have an increased frequency of high MIF expression CATT alleles. Higher Mif expression increases the incidence of mortality and pulmonary granulomas in Mif lung-Tg2.1 mice, while anti-MIF treatment protects these mice against death. Blockade of MIF in high genotypic MIF expressers may therefore offer a selective pharmacologic therapy for GPA.
引用
- Sreih AG, Ezzedine R, Leng L, et al. Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2018. PMID: 29953750. doi:10.1002/art.40655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。